Mirati Therapeutics

IRS: 462693615
MRTX

Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States.

Founded
2013 (10 years)
Investor RelationsSEC
Revenue
12 million (2022)

Want to see more? Sign up!